Patent AnalyticsExaminers
Rankings

Company or institution

CIPLA LIMITED

271 applicationsfiled 2006 to 2026

Allowance rate
56%
−19 pts vs the USPTO range 50% to 62%
Rejections before allowance
1.8
+0.2 vs the USPTO
Months to first action
14.8 mo
−3.8 vs the USPTO
Needed an RCE
26%
level with the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations155 apps
C07D Heterocyclic compounds63 apps
A61M Devices for introducing media into the body13 apps
C07C 13 apps
C07F 9 apps
A61P Therapeutic activity of compounds8 apps

Art units

162528 apps
162425 apps
162220 apps
162920 apps
161519 apps
162117 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19679331PARENTERAL FORMULATIONS OF NIMODIPINE2026-05-15Pending103.5 mo
19451486Pharmaceutical Formulation2026-01-16Pending00n/a
19410805STABLE AQUEOUS INJECTABLE FORMULATION OF FLUCYTOSINE2025-12-05Pending206.6 mo
15518954Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15371611Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15753571Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15778402Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15323520Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15665309Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15809751Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 271 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in